tiprankstipranks
Trending News
More News >

GoodRx backs FY25 revenue view $810M-$840M, consensus $823.27M

Raises FY25 adjusted EBITDA view to $273M-$287M from $270M-$286M.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1